Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 14 January 2009, doi:10.1136/bmj.a3147
Cite this as: BMJ 2009;338:a3147
Kinta Beaver, professor of nursing1, Debbie Tysver-Robinson, nurse consultant2, Malcolm Campbell, lecturer in statistics1, Mary Twomey, research associate1, Susan Williamson, research fellow1, Andrew Hindley, consultant clinical oncologist3, Shabbir Susnerwala, consultant clinical oncologist3, Graham Dunn, professor of biomedical statistics4, Karen Luker, professor of nursing1
1 School of Nursing, Midwifery and Social Work, University of Manchester, Manchester M13 9PL, 2 Blackpool, Fylde and Wyre Hospitals NHS Foundation Trust, Blackpool, Lancashire, 3 Rosemere Cancer Centre, Royal Preston Hospital, Preston, Lancashire, 4 Health Methodology Research Group, University of Manchester, Manchester
Correspondence to: K Beaver kinta.beaver{at}manchester.ac.uk
Design A two centre randomised equivalence trial in which women remained in the study for a mean of 24 months.
Setting Outpatient clinics in two NHS hospital trusts in the north west of England
Participants 374 women treated for breast cancer who were at low to moderate risk of recurrence.
Interventions Participants were randomised to traditional hospital follow-up (consultation, clinical examination, and mammography as per hospital policy) or telephone follow-up by specialist nurses (consultation with structured intervention and mammography according to hospital policy).
Main outcome measures Psychological morbidity (state-trait anxiety inventory, general health questionnaire (GHQ-12)), participants needs for information, participants satisfaction, clinical investigations ordered, and time to detection of recurrent disease.
Results The 95% confidence interval for difference in mean state-trait scores adjusted for treatment received (–3.33 to 2.07) was within the predefined equivalence region (–3.5 to 3.5). The women in the telephone group were no more anxious as a result of foregoing clinic examinations and face-to-face consultations and reported higher levels of satisfaction than those attending hospital clinics (intention to treat P<0.001). The numbers of clinical investigations ordered did not differ between groups. Recurrences were few (4.5%), with no differences between groups for time to detection (median 60.5 (range 37-131) days in hospital group v 39.0 (10-152) days in telephone group; P=0.228).
Conclusions Telephone follow-up was well received by participants, with no physical or psychological disadvantage. It is suitable for women at low to moderate risk of recurrence and those with long travelling distances or mobility problems and decreases the burden on busy hospital clinics.
Trial registration National Cancer Research Institute 1477.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?